Short Treatment with the Angiotensin Receptor Blocker Candesartan Surveyed by Telemedicine [STAR-CAST]

Trial Profile

Short Treatment with the Angiotensin Receptor Blocker Candesartan Surveyed by Telemedicine [STAR-CAST]

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Dec 2013

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Nifedipine
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms STAR CAST; STAR-CAST
  • Most Recent Events

    • 30 Jun 2013 Status changed from recruiting to completed.
    • 17 Jun 2013 Results presented at the 23rd European Meeting on Hypertension.
    • 21 Jul 2010 A total of 187 patients have been enrolled in the study so far, according to an abstract presented at the 20th European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top